Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

    NEXT STORY
    CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
    PREV STORY
    Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global In-Vitro Diagnostics Market Will Reach USD 87.3 Billion by 2024: Zion Market Research

    According to the report, global in-vitro diagnostics market was valued at around USD 62.0 ...

    author_avatar
    NASDAQ Market News

    BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment

    author_avatar
    NASDAQ Market News

    Immutep Upscales Efti Manufacturing

    author_avatar
    NASDAQ Market News